Literature DB >> 15150165

Entamoeba histolytica alcohol dehydrogenase 2 (EhADH2) as a target for anti-amoebic agents.

Avelina Espinosa1, David Clark, Samuel L Stanley.   

Abstract

OBJECTIVES: The current use of metronidazole as an anti-amoebic agent causes significant side-effects. The purpose of this study was to identify alternative compounds with which to treat amoebiasis.
METHODS: We tested the effects of cyclopropyl (CPC) and cyclobutyl (CBC) carbinols on the survival of Entamoeba histolytica trophozoites and on the enzymatic activities of E. histolytica alcohol dehydrogenase 2 (EhADH2), a crucial enzyme in the amoebic fermentation pathway.
RESULTS: At 72 h, the estimated 50% inhibitory concentrations of CPC and CBC were 38.9 and 11.2 microM, respectively. The EhADH2 alcohol and aldehyde dehydrogenase activities were inhibited by 1.82 microM CPC and 0.89 microM CBC in vitro.
CONCLUSIONS: CPC and CBC are expected to be non-toxic to humans at the concentrations required to eliminate E. histolytica trophozoites. Similarities between EhADH2 and the Giardia lamblia AdhE enzyme indicate that CPC and CBC could be effective drugs for treatment of both amoebiasis and giardiasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150165     DOI: 10.1093/jac/dkh280

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

Review 1.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

2.  The Entamoeba histolytica Dnmt2 homolog (Ehmeth) confers resistance to nitrosative stress.

Authors:  Rivi Hertz; Ayala Tovy; Michael Kirschenbaum; Meirav Geffen; Tomoyoshi Nozaki; Noam Adir; Serge Ankri
Journal:  Eukaryot Cell       Date:  2014-02-21

3.  Molecular analysis of an NAD-dependent alcohol dehydrogenase from the zygomycete Mucor circinelloides.

Authors:  R A Rangel-Porras; V Meza-Carmen; G Martinez-Cadena; J C Torres-Guzmán; G A González-Hernández; J Arnau; J F Gutiérrez-Corona
Journal:  Mol Genet Genomics       Date:  2005-09-23       Impact factor: 3.291

4.  Integrating horizontal gene transfer and common descent to depict evolution and contrast it with "common design".

Authors:  Guillermo Paz-Y-Miño C; Avelina Espinosa
Journal:  J Eukaryot Microbiol       Date:  2009-12-18       Impact factor: 3.346

5.  Antiamoebic properties of the actinomycete metabolites echinomycin A and tirandamycin A.

Authors:  Avelina Espinosa; Aaron M Socha; Erica Ryke; David C Rowley
Journal:  Parasitol Res       Date:  2012-07-05       Impact factor: 2.289

6.  Bioinformatics Structural and Phylogenetic Characterization of Entamoeba histolytica Alcohol Dehydrogenase 2 (EhADH2).

Authors:  Katie M Lowerre; Avelina Espinosa; Guillermo Paz-Y-Miño-C; Christopher Hemme
Journal:  Bios       Date:  2019-10-26

7.  Effects of iron depletion on Entamoeba histolytica alcohol dehydrogenase 2 (EhADH2) and trophozoite growth: implications for antiamoebic therapy.

Authors:  Avelina Espinosa; George Perdrizet; Guillermo Paz-Y-Miño C; Regine Lanfranchi; Monichan Phay
Journal:  J Antimicrob Chemother       Date:  2009-02-13       Impact factor: 5.790

8.  Anti-amebic effects of Chinese rhubarb (Rheum palmatum) leaves' extract, the anthraquinone rhein and related compounds.

Authors:  Avelina Espinosa; Guillermo Paz-Y-Miño-C; Yoly Santos; Hang Ma; Michael Nadeau; Navindra P Seeram; David C Rowley
Journal:  Heliyon       Date:  2020-04-01

Review 9.  Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis.

Authors:  Manish T Shrivastav; Zainab Malik
Journal:  Front Cell Infect Microbiol       Date:  2021-02-24       Impact factor: 5.293

10.  Proteomic identification of S-nitrosylated proteins in the parasite Entamoeba histolytica by resin-assisted capture: insights into the regulation of the Gal/GalNAc lectin by nitric oxide.

Authors:  Rivka Hertz; Shani Ben Lulu; Preeti Shahi; Meirav Trebicz-Geffen; Moran Benhar; Serge Ankri
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.